Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: de Waal, Margaret Suzanne
Other Authors: Everingham, Geoff
Format: Thesis
Language:English
Published: College of Accounting 2016
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613586244763648
access_status_str Open Access
author de Waal, Margaret Suzanne
author2 Everingham, Geoff
author_browse Everingham, Geoff
de Waal, Margaret Suzanne
author_facet Everingham, Geoff
de Waal, Margaret Suzanne
author_sort de Waal, Margaret Suzanne
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/17534
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:38:30.173Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2016
publishDateRange 2016
publishDateSort 2016
publisher College of Accounting
publisherStr College of Accounting
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/17534 The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study de Waal, Margaret Suzanne Everingham, Geoff Accounting Pharmaceutical Industry Research and Development costs Includes bibliographical references. Research and development spending has become increasingly important over the last two decades. Despite this, the South African business community has largely ignored the South African accounting standard for research and development costs, AC 122, issued in 1994. A review of the comments received from a number of respondents to the exposure draft to AC 122 and it's international equivalent, lAS 9 (revised), suggests that the implementation difficulties associated with AC 122 are the major reason for the apparent lack of acceptance of AC 122 by the local accounting profession and industry. This research attempts to identify these implementation concerns, specifically in relation to the pharmaceutical industry, so as to provide guidance for implementing AC 122 in this industry. From an analysis performed of AC 122 and the responses of a number of members of the local and global business community, three main implementation problems associated with AC 122 were identified. These are (a) the appropriate allocation of R & D costs between research costs and development costs, (b) implementing the requirement to capitalise development costs, and (c) determining the most appropriate method and time period for amortising a development asset. The identification of these problems also highlighted that AC 122 is deficient in implementation guidance and requires the exercise of an unusually high level of subjective judgement. This study illustrates that it is possible to develop guidelines for overcoming the problems identified in the pharmaceutical industry. This research also provides an approach for similar research in other R & D intensive industries. However, the time and cost of performing such an exercise is likely to limit the industry approach to accounting for R & D costs. The research led to the conclusion that the accounting standard for research and development costs in South Africa is difficult to apply consistently in practice, and requires amendment if it is to obtain the support of the accountancy profession and commerce. 2016-03-07T04:13:12Z 2016-03-07T04:13:12Z 1998 Master Thesis Masters MCom http://hdl.handle.net/11427/17534 eng application/pdf College of Accounting Faculty of Commerce University of Cape Town
spellingShingle Accounting
Pharmaceutical Industry
Research and Development costs
de Waal, Margaret Suzanne
The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
thesis_degree_str Master's
title The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
title_full The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
title_fullStr The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
title_full_unstemmed The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
title_short The application of AC 122 to research and development, in the pharmaceutical industry : conceptual issues and implementation concerns : a case study
title_sort application of ac 122 to research and development in the pharmaceutical industry conceptual issues and implementation concerns a case study
topic Accounting
Pharmaceutical Industry
Research and Development costs
url http://hdl.handle.net/11427/17534
work_keys_str_mv AT dewaalmargaretsuzanne theapplicationofac122toresearchanddevelopmentinthepharmaceuticalindustryconceptualissuesandimplementationconcernsacasestudy
AT dewaalmargaretsuzanne applicationofac122toresearchanddevelopmentinthepharmaceuticalindustryconceptualissuesandimplementationconcernsacasestudy